Publications
50
Citations
357
Est. group size
~6
Recurring co-author estimate
Active years
17
Publishing since 2010
Jeremy Brownstein works in radiation oncology, studying how radiation and related therapies affect cancer treatment and normal tissue side effects. His work spans clinical trials for lung cancer, preclinical animal studies of radiation-induced heart and blood vessel injury, and novel treatment approaches like carbon ion therapy, proton beam therapy, and localized radioactive drug delivery for tumors such as sarcomas and pancreatic cancer.
Publication output grew steadily from 2017 to a peak in 2023, followed by a decline to a more moderate but still active pace through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005
Journal of Clinical Oncology · 2026
- Data from Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
2023
- Supplementary Figure 3 from Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
2023
- Supplementary Figure 1 from Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
2023
- Supplementary Figure 2 from Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
2023
- Supplementary Table 1 from Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
2023
- Supplementary Figure 2 from Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
2023
- Supplementary Table 1 from Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
2023
- Supplementary Figure 3 from Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
2023
- Supplementary Figure 1 from Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
2023
- Data from Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
2023
- Brachytherapy via a depot of biopolymer-bound 131I synergizes with nanoparticle paclitaxel in therapy-resistant pancreatic tumours
Nature Biomedical Engineering · 2022
- Moderately Hypofractionated Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: A New Way Forward for Dose Escalation?
International Journal of Radiation Oncology*Biology*Physics · 2022
- A Single Institution's Experience with Cardiac Radioablation Utilizing the 17-Segment Model for Target Localization
International Journal of Radiation Oncology*Biology*Physics · 2022
- Characterization of cardiovascular injury in mice following partial-heart irradiation with clinically relevant dose and fractionation
Radiotherapy and Oncology · 2021
- International Journal of Radiation Oncology*Biology*Physics×8
- Journal of Clinical Oncology×3
- Hematology/Oncology Clinics of North America×2
- Radiation Research×2
- Heart Rhythm×2
- Li Zhao
Medicine · Purdue University West Lafayette
- A. Foster
Medicine · Indiana University
- Peter J. Kneuertz
Medicine · The Ohio State University
- Daniel Jones
Medicine · The Ohio State University
- Manny Coker‐Schwimmer
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile